Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

Clinical trial NCT05165550 · COMPLETED

Trial details

NCT number: NCT05165550
Sponsor: Viriom
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2022-04-12
Primary completion: 2022-07-13
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.